SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001140361-24-022440
Filing Date
2024-04-26
Accepted
2024-04-26 16:08:35
Documents
21
Period of Report
2024-06-05

Document Format Files

Seq Description Document Type Size
1 DEF 14A ny20022201x1_def14a.htm   iXBRL DEF 14A 1814421
6 logo_nektar.jpg GRAPHIC 14135
7 ny20022201x1_barchart01.jpg GRAPHIC 176572
8 ny20022201x1_pvp01.jpg GRAPHIC 159363
9 ny20022201x1_pvp02.jpg GRAPHIC 157736
10 ny20022201x1_pvp03.jpg GRAPHIC 164233
11 ny20022201x1-pc_1.jpg GRAPHIC 605328
12 ny20022201x1-pc_2.jpg GRAPHIC 595658
  Complete submission text file 0001140361-24-022440.txt   7450191

Data Files

Seq Description Document Type Size
2 INLINE XBRL TAXONOMY EXTENSION - SCHEMA nktr-20240605.xsd EX-101.SCH 4805
3 INLINE XBRL TAXONOMY EXTENSION - DEFINITION LINKBASE nktr-20240605_def.xml EX-101.DEF 5397
4 INLINE XBRL TAXONOMY EXTENSION - LABEL LINKBASE nktr-20240605_lab.xml EX-101.LAB 10154
5 INLINE XBRL TAXONOMY EXTENSION - PRESENTATION LINKBASE nktr-20240605_pre.xml EX-101.PRE 4703
24 EXTRACTED XBRL INSTANCE DOCUMENT ny20022201x1_def14a_htm.xml XML 215761
Mailing Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158
Business Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158 4154825300
NEKTAR THERAPEUTICS (Filer) CIK: 0000906709 (see all company filings)

IRS No.: 943134940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-24006 | Film No.: 24883700
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)